Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - GROSS PROFIT
Gross Profit KALV - KalVista Pharmaceuticals, Inc.
-86.2 M
LAST VALUE
-976.90%
2 YEAR CAGR
-44.75%
5 YEAR CAGR
-70.58%
10 YEAR CAGR